Skip to main content
. 2024 Jul 3;68:10.29219/fnr.v68.10674. doi: 10.29219/fnr.v68.10674

Table 3.

The changed in biochemical data during the supplementation period

Variables Groups (number) Δ8th week Δ20th week Δ36th week Δ44th week ΔE-12th week ΔE-24th week
WBC (103/uL) control (n = 7) 0.2 ± 2.59 0.67 ± 4.04 - - - -
fucoidan (n = 13) 0 ± 2.31 1 ± 2 1 ± 2.64 –1 ± 2.83 –2.5 ± 4.9 7 ± 5.66
Albumin control (n = 7) 0 ± 0.71 –0.33 ± 0.58 - - - -
fucoidan (n = 13) 0.29 ± 0.49 0 ± 0 0 ± 0 0 ± 0 0 ± 0 –0.5 ± 0.71
Pre-albumin control (n = 7) –0.86 ± 6.81 –11.05 ± 4.03 - - - -
fucoidan (n = 13) 3.19 ± 8.98 –0.28 ± 8.05 –3.05 ± 3.46 - –2.65 ± 2.33 6.95 ± 4.03
Transferrin control (n = 7) 23.12 ± 88.39 –34 ± 41.79 - - - -
fucoidan (n = 13) 29.92 ± 30.15 9 ± 7.45 - - - -
T-Protein control (n = 7) –0.6 ± 1.14 1 ± 1 - - - -
fucoidan (n = 13) 0.29 ± 0.48 0.33 ± 0.51 0.5 ± 0.71 0 ± 1.41 0.5 ± 0.71 0 ± 1.41
GOT (U/L) control (n = 7) 3.6 ± 8.73 5.33 ± 13.05 - - - -
fucoidan (n = 13) –1.86 ± 9.74 –4.67 ± 10.5 –4.33 ± 13.86 –7.5 ± 9.19 17 ± 21.92 –4.5 ± 2.12
GPT (U/L) control (n = 7) 4.6 ± 8.65 4 ± 8.18 - - - -
fucoidan (n = 13) 1.57 ± 17.71 –2.7 ± 11.83 –5.67 ± 7.76 –7.5 ± 2.12 6 ± 18.38 –5 ± 9.89
BUN (mg/dl) control (n = 7) –5 ± 2.5 –4.67 ± 6.65 - - - -
fucoidan (n = 13) 2 ± 5.47 3.67 ± 6.5 –1.67 ± 2.08 2.5 ± 7.77 –1.5 ± 0.7 -
Creatinine (mg/dl) control (n = 7) –0.04 ± 0.16 –0.08 ± 0.235 - - - -
fucoidan (n = 13) 0.06 ± 0.08 0 ± 0.13 0.053 ± 0.098 –0.01 ± 0.16 –0.02 ± 0.233 –O.U ± 2.32
TG (mg/dl) control (n = 7) - - - - - -
fucoidan (n = 13) - –8.4 ± 94.13 –89.25 ± 80 - –82.5 ± 136.47 –95.5 ± 147.78
Choloesterol(mg/dl) control (n = 7) - - 61 ± 79. 19 - - -
fucoidan (n = 13) - –8.8 ± 20.6 –9.5 ± 13.43 - - –12.5 ± 57.27

WBC = White blood cell; NLR = neutrophil-to-lymphocyte ratio; GOT = aspartate aminotransferase; GPT = alanine aminotransferase; BUN = blood urea nitrogen; TG = Triglyceride; E = during follow period.

∆: The changed concentrations of cytokines (supplementation week – 0 week).